<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03164083</url>
  </required_header>
  <id_info>
    <org_study_id>SCARM-Osteoarthritis-001</org_study_id>
    <nct_id>NCT03164083</nct_id>
  </id_info>
  <brief_title>The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis</brief_title>
  <official_title>Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SCARM Institute, Tabriz, Iran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SCARM Institute, Tabriz, Iran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis of the knee is one of the most common causes of disability among elderly. As
      the disease progresses the cartilage become frustrated, surrounding bone react to become
      thicker and inflammation occurs in subchondral bone seen in T2-weighted MRI as increase in
      signal density. Patients are treated initially by pain management. In patients who don't
      response to first line treatment invasive treatment like total knee replacement is done. The
      investigators designed this clinical study with the aim of evaluating therapeutic effects of
      intra-articular injection of bone marrow Mesenchymal Stem Cells (MSC) and stromal Vascular
      Fraction (SVF) in patients with severe knee osteoarthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is single center, randomized, triple blind phase II clinical study. Patients will be
      divided into two groups of case and control. All subjects will undergo bone marrow
      aspiration. Mesenchymal Stem Cells will be isolated from bone marrow and stromal Vascular
      Fraction fram lipoaspirate, cultured and transplanted back to the knee joint. Patients of
      case group will receive cell injection 1 and 4 months after bone marrow aspiration. Placebo
      will be administered in this group 6 months after the first injection. Patients of control
      group will receive placebo 1 and 4 months after bone marrow aspiration. They all receive cell
      injection 6 months after first placebo injection. Follow up visit will occur at 2 and 6
      weeks, and 3 and 6 months after the first injection. Radiological exams will be performed
      before and 6 months after the first injection by MRI. Clinical quantitative assessment will
      measure joint function by the WOMAC index and pain by the visual analogue scale
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 10, 2018</start_date>
  <completion_date type="Anticipated">November 5, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 21, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>physical function improvement</measure>
    <time_frame>2 weeks</time_frame>
    <description>Evaluation the physical function improvement Measured by WOMAC osteoarthritis index after cell injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in pain density</measure>
    <time_frame>2 weeks</time_frame>
    <description>Evaluation the changing of pain density measured by Visual Analogue Scale after cell injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Joint swelling</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation the joint swelling by physical examination after intra articular cell injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Joint erythema</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation the joint erythema by physical examination after cell injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Deterioration of joint function</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation the deterioration of joint function by physical examination after intra articular cell injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Allergic reactions</measure>
    <time_frame>3 months</time_frame>
    <description>Evaluation the allergic reactions like skin rash,skin erythema, dyspnea by physical examination after cell injection</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>mesenchymal stem cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with knee joint osteoarthritis who underwent intra articular mesenchymal stem cell injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients who are in control group and underwent placebo injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mesenchymal stem cell</intervention_name>
    <description>intra articular injection of mesenchymal stem cell Other Name: stem cell transplantation</description>
    <arm_group_label>mesenchymal stem cell</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients with knee joint osteoarthritis who underwent intra articular placebo injection</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthritis diagnosed by MRI

        Exclusion Criteria:

          -  Pregnancy or lactating

          -  Positive tests for HIV, Hepatitis C virus (HCV), Hepatitis C virus (HBV)

          -  Active neurologic disorder

          -  End organ damage

          -  Uncontrolled endocrine disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Nouri, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Head of SCARM Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peyman Keyhanvar, MD, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Deputy for translational medicine of SCARM institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seyed Kazem Shakouri, Physiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tabriz University of Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neda keyhanvar, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>SCARM institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sepideh Bastani, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>SCARM institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Peyman Keyhanvar, MD, Ph.D</last_name>
    <phone>0914 114 6863</phone>
    <email>drkeyhanvar@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SCARM Institute</name>
      <address>
        <city>Tabriz</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peyman Keyhanvar, MD, Ph.D</last_name>
    </contact>
    <contact_backup>
      <last_name>Neda keyhanvar, Ph.D</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Pak J, Lee JH, Park KS, Park M, Kang LW, Lee SH. Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications. J Biomed Sci. 2017 Jan 31;24(1):9. doi: 10.1186/s12929-017-0318-z. Review.</citation>
    <PMID>28143470</PMID>
  </results_reference>
  <results_reference>
    <citation>Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage Regeneration in Human with Adipose Tissue-Derived Stem Cells: Current Status in Clinical Implications. Biomed Res Int. 2016;2016:4702674. doi: 10.1155/2016/4702674. Epub 2016 Jan 6. Review.</citation>
    <PMID>26881220</PMID>
  </results_reference>
  <results_reference>
    <citation>Koh YG, Choi YJ, Kwon SK, Kim YS, Yeo JE. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1308-16. doi: 10.1007/s00167-013-2807-2. Epub 2013 Dec 11.</citation>
    <PMID>24326779</PMID>
  </results_reference>
  <results_reference>
    <citation>Pires de Carvalho P, Hamel KM, Duarte R, King AG, Haque M, Dietrich MA, Wu X, Shah F, Burk D, Reis RL, Rood J, Zhang P, Lopez M, Gimble JM, Dasa V. Comparison of infrapatellar and subcutaneous adipose tissue stromal vascular fraction and stromal/stem cells in osteoarthritic subjects. J Tissue Eng Regen Med. 2014 Oct;8(10):757-62. doi: 10.1002/term.1565. Epub 2012 Jul 16.</citation>
    <PMID>22807102</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>January 3, 2018</last_update_submitted>
  <last_update_submitted_qc>January 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Joint Diseases</keyword>
  <keyword>Musculoskeletal Diseases</keyword>
  <keyword>Arthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

